Try our beta test site
1 study found for:    20133895 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed Study of SGN-40 in Patients With Refractory or Recurrent Multiple Myeloma
Condition: Multiple Myeloma
Intervention: Drug: SGN-40 (anti-huCD40 mAb)

Study has passed its completion date and status has not been verified in more than two years.